SHILPAMEDPharmaceuticals
Shilpa Medicare Ltd — Profit & Loss Statement
₹348.90
+0.75%
Shilpa Medicare Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Unusual Items | -28.08 Cr | 6.13 Cr | -1.07 Cr | 1.77 Cr | — |
| Total Unusual Items Excluding Goodwill | -28.08 Cr | 6.13 Cr | -1.07 Cr | 1.77 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 78.29 Cr | 31.87 Cr | -32.53 Cr | 60.66 Cr | — |
| Reconciled Depreciation | 112.99 Cr | 107.87 Cr | 95.50 Cr | 79.80 Cr | — |
| Reconciled Cost Of Revenue | 410.37 Cr | 407.55 Cr | 416.84 Cr | 384.10 Cr | — |
| EBITDA | 310.86 Cr | 254.02 Cr | 113.47 Cr | 223.00 Cr | — |
| EBIT | 197.87 Cr | 146.15 Cr | 17.98 Cr | 143.20 Cr | — |
| Net Interest Income | -75.53 Cr | -91.81 Cr | -56.89 Cr | -38.92 Cr | — |
| Interest Expense | 75.53 Cr | 91.81 Cr | 56.25 Cr | 40.93 Cr | — |
| Normalized Income | 96.27 Cr | 27.58 Cr | -31.67 Cr | 59.43 Cr | — |
| Net Income From Continuing And Discontinued Operation | 78.29 Cr | 31.87 Cr | -32.53 Cr | 60.66 Cr | — |
| Total Expenses | 1.08K Cr | 1.01K Cr | 1.05K Cr | 1.01K Cr | — |
| Diluted Average Shares | 9.74 Cr | 8.69 Cr | 8.68 Cr | 8.35 Cr | — |
| Basic Average Shares | 9.74 Cr | 8.69 Cr | 8.68 Cr | 8.35 Cr | — |
| Diluted EPS | 8.04 | 3.67 | -3.75 | 7.26 | — |
| Basic EPS | 8.04 | 3.67 | -3.75 | 7.26 | — |
| Diluted NI Availto Com Stockholders | 78.29 Cr | 31.87 Cr | -32.53 Cr | 60.66 Cr | — |
| Net Income Common Stockholders | 78.29 Cr | 31.87 Cr | -32.53 Cr | 60.66 Cr | — |
| Otherunder Preferred Stock Dividend | 1000.00 | 1000.00 | 0.00 | 0.00 | — |
| Net Income | 78.29 Cr | 31.87 Cr | -32.53 Cr | 60.66 Cr | — |
| Minority Interests | -38000.00 | -0.08 Cr | -1.56 Cr | 0.08 Cr | — |
| Net Income Including Noncontrolling Interests | 78.30 Cr | 31.96 Cr | -30.97 Cr | 60.58 Cr | — |
| Net Income Continuous Operations | 78.30 Cr | 31.96 Cr | -30.97 Cr | 60.58 Cr | — |
| Tax Provision | 44.04 Cr | 22.39 Cr | -7.31 Cr | 41.68 Cr | — |
| Pretax Income | 122.33 Cr | 54.34 Cr | -38.28 Cr | 102.26 Cr | — |
| Other Non Operating Income Expenses | 23.15 Cr | 8.17 Cr | 14.07 Cr | 10.77 Cr | — |
| Special Income Charges | -28.08 Cr | 6.13 Cr | -1.07 Cr | 1.77 Cr | — |
| Other Special Charges | 29.10 Cr | -6.13 Cr | 0.26 Cr | -7.19 Cr | — |
| Write Off | -1.02 Cr | 4.72 Cr | 0.80 Cr | 5.42 Cr | — |
| Net Non Operating Interest Income Expense | -75.53 Cr | -91.80 Cr | -56.89 Cr | -38.92 Cr | — |
| Interest Expense Non Operating | 75.53 Cr | 91.81 Cr | 56.25 Cr | 40.93 Cr | — |
| Operating Income | 204.06 Cr | 136.63 Cr | -4.60 Cr | 125.83 Cr | — |
| Operating Expense | 671.98 Cr | 607.42 Cr | 631.20 Cr | 630.12 Cr | — |
| Other Operating Expenses | 266.28 Cr | 218.06 Cr | 160.85 Cr | 161.81 Cr | — |
| Depreciation And Amortization In Income Statement | 112.99 Cr | 107.87 Cr | 95.50 Cr | 79.80 Cr | — |
| Depreciation Income Statement | 112.99 Cr | 107.87 Cr | 95.50 Cr | 79.80 Cr | — |
| Gross Profit | 876.04 Cr | 743.57 Cr | 626.60 Cr | 755.95 Cr | — |
| Cost Of Revenue | 410.37 Cr | 407.55 Cr | 416.84 Cr | 384.10 Cr | — |
| Total Revenue | 1.29K Cr | 1.15K Cr | 1.04K Cr | 1.14K Cr | — |
| Tax Effect Of Unusual Items | -10.11 Cr | 1.84 Cr | -0.20 Cr | 0.53 Cr | — |
| Tax Rate For Calcs | 0.36 | 0.30 | 0.19 | 0.30 | — |
| Normalized EBITDA | 338.94 Cr | 247.89 Cr | 114.54 Cr | 221.23 Cr | — |
| Operating Revenue | 1.29K Cr | 1.15K Cr | 1.04K Cr | 1.14K Cr | — |
| Interest Income | — | 1.38 Cr | 1.76 Cr | 2.07 Cr | 3.44 Cr |
| Rent Expense Supplemental | — | 1.25 Cr | 1.01 Cr | 1.16 Cr | 1.46 Cr |
| Total Other Finance Cost | — | 8.08 Cr | 2.40 Cr | 0.06 Cr | 0.16 Cr |
| Interest Income Non Operating | — | 1.38 Cr | 1.76 Cr | 2.07 Cr | 3.44 Cr |
| Research And Development | — | 30.96 Cr | 49.10 Cr | 55.06 Cr | 33.81 Cr |
| Selling General And Administration | — | 24.70 Cr | 32.15 Cr | 60.89 Cr | 47.64 Cr |
| Selling And Marketing Expense | — | 2.87 Cr | 2.62 Cr | 5.66 Cr | 11.92 Cr |
| General And Administrative Expense | — | 21.84 Cr | 29.53 Cr | 55.23 Cr | 35.72 Cr |
| Rent And Landing Fees | — | 1.25 Cr | 1.01 Cr | 1.16 Cr | 1.46 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Shilpa Medicare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.